Jasper Therapeutics (JSPR) Interest Coverage Ratio (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Interest Coverage Ratio of 31.93 for Q4 2025, up 62.87% year-over-year from 19.61 in Q4 2024, and up 90.84% quarter-over-quarter from 348.47 in Q3 2025.
Jasper Therapeutics (JSPR) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 31.93 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 62.87% year-over-year to 31.93; the TTM figure through Dec 2025 stood at 62.09 (up 30.37% YoY), while the FY2025 annual figure was 46.01, down 298.82% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 31.93, up from 348.47 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 78.97 in Q4 2021, with the low at 348.47 in Q3 2025.
- The 5-year median for Interest Coverage Ratio is 25.59 (2021), against an average of 50.67.
- The sharpest annual moves came in 2021 and 2025: Interest Coverage Ratio jumped 321.34% in 2021, then plunged 6673.57% in 2025.
- Jasper Therapeutics' Interest Coverage Ratio stood at 78.97 in 2021, then slumped by 120.58% to 16.25 in 2022, then sank by 282.74% to 62.19 in 2023, then plunged by 38.28% to 86.0 in 2024, then surged by 62.87% to 31.93 in 2025.
- Business Quant data shows JSPR's Interest Coverage Ratio at 31.93 in Q4 2025, 348.47 in Q3 2025, and 12.05 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.93 |
| Sep 30, 2025 | -348.47 |
| Jun 30, 2025 | -12.05 |
| Mar 31, 2025 | -159.14 |
| Dec 31, 2024 | -86.00 |
| Sep 30, 2024 | -5.14 |
| Jun 30, 2024 | -33.46 |
| Mar 31, 2024 | -21.26 |
| Dec 31, 2023 | -62.19 |
| Sep 30, 2023 | -5.75 |
| Jun 30, 2023 | -15.02 |
| Mar 31, 2023 | -50.53 |
| Dec 31, 2022 | -16.25 |
| Sep 30, 2022 | -17.10 |
| Jun 30, 2022 | -119.63 |
| Mar 31, 2022 | -2.57 |
| Dec 31, 2021 | 78.97 |
| Jun 30, 2021 | -25.59 |
| Mar 31, 2021 | -29.64 |
| Dec 31, 2020 | -35.68 |